![]() Ruzotolimod structure
|
Common Name | Ruzotolimod | ||
---|---|---|---|---|
CAS Number | 1948241-60-8 | Molecular Weight | 354.38 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C14H18N4O5S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of RuzotolimodRuzotolimod is the agonist of TLR7. Ruzotolimod has the potential for the research of HBV, COVID-19 or SARS-CoV-2 infection (extracted from patent WO2021130195A1)[1]. |
Name | Ruzotolimod |
---|
Description | Ruzotolimod is the agonist of TLR7. Ruzotolimod has the potential for the research of HBV, COVID-19 or SARS-CoV-2 infection (extracted from patent WO2021130195A1)[1]. |
---|---|
Related Catalog | |
Target |
TLR7[1] |
References |
[1]. Qingyan BO, et al. Method of treating virus infection using a tlr7 agonist. Patent WO2021130195A1. |
Molecular Formula | C14H18N4O5S |
---|---|
Molecular Weight | 354.38 |